Atox NSTI-A Multicenter Retrospective Study to Evaluate the Effect of Standard of Care Treatment in Patients Diagnosed with Necrotizing Soft Tissue Infections

Grants and Contracts Details

StatusFinished
Effective start/end date6/18/145/30/16

Funding

  • Atox Bio: $13,000.00